Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hepadvax
- Development stage
- Phase 2
- Lead developer
- Vaxine
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
**Hepadvax** is Vaxine's investigational adjuvanted hepatitis B vaccine being developed as a therapeutic vaccine for chronic hepatitis B virus infection. The registered HBV003 study describes the experimental vaccine as preS hepatitis B surface antigen formulated with Advax-2, an adjuvant system containing delta-inulin microparticles and CpG oligonucleotides. The intended mechanism is to enhance hepatitis B surface antigen-specific humoral and cellular immunity, including antiviral T-cell responses, to support HBV viral control and potentially hepatitis B surface antigen seroconversion in chronically infected individuals. It has been studied previously in prophylactic hepatitis B vaccine development and is registered for a Phase 1 chronic hepatitis B study. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03038802))
- Brand names
- Hepadvax
- Other names
- therapeutic hepatitis B vaccine
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on Hepadvax.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepadvax.